S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Bio Medica Co. stock logo
ABMC
American Bio Medica
$0.00
$0.00
$0.00
$0.02
N/A-0.657,148 shs2,570 shs
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
$1.41
-6.0%
$2.88
$0.73
$6.60
$16.14M1.173.10 million shs46,491 shs
Global Future City Holding Inc stock logo
FTCY
Global Future City
$0.00
$0.05
$1.00
$2.04M-0.614,221 shs16 shs
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
$3.00
$1.50
$19.37
$7.07M2.899,592 shs4,300 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Bio Medica Co. stock logo
ABMC
American Bio Medica
0.00%0.00%0.00%+200.00%-97.78%
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
+1.35%-17.58%-10.71%-37.50%+32.74%
Global Future City Holding Inc stock logo
FTCY
Global Future City
0.00%0.00%0.00%0.00%0.00%
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Bio Medica Co. stock logo
ABMC
American Bio Medica
N/AN/AN/AN/AN/AN/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Bio Medica Co. stock logo
ABMC
American Bio Medica
N/AN/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/A
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Bio Medica Co. stock logo
ABMC
American Bio Medica
$910KN/AN/AN/A($0.05) per shareN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/A$1.57 per shareN/A
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
$23.99M0.00N/AN/A$0.05 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Bio Medica Co. stock logo
ABMC
American Bio Medica
-$1.41MN/A0.00N/AN/AN/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
-$8.75MN/A0.00N/AN/AN/AN/AN/A
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
-$8.28M-$4.16N/A0.00N/A-34.51%-682.54%-78.57%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Bio Medica Co. stock logo
ABMC
American Bio Medica
N/AN/AN/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/AN/A
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Bio Medica Co. stock logo
ABMC
American Bio Medica
N/AN/AN/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/A
3.83
3.83
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/A
0.68
0.36

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Bio Medica Co. stock logo
ABMC
American Bio Medica
N/A
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
6.03%
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
10.38%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Bio Medica Co. stock logo
ABMC
American Bio Medica
16N/AN/ANot Optionable
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
132,20011.42 millionN/ANot Optionable
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/A40.66 millionN/ANot Optionable
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
122.36 millionN/ANot Optionable

FTCY, ABMC, EARS, and INNVD Headlines

SourceHeadline
Inovio Pharmaceuticals Stock Is Diving Today: Whats Happening?Inovio Pharmaceuticals Stock Is Diving Today: What's Happening?
msn.com - April 16 at 2:01 PM
Syros Pharmaceuticals, Inc. Common Stock (SYRS)Syros Pharmaceuticals, Inc. Common Stock (SYRS)
nasdaq.com - April 11 at 3:56 PM
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion DealVertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
msn.com - April 10 at 6:13 PM
Innovus Pharmaceuticals (OTCMKTS:INNVD) Trading 143.9% Higher Innovus Pharmaceuticals (OTCMKTS:INNVD) Trading 143.9% Higher
americanbankingnews.com - April 9 at 1:42 AM
Supernus Pharmaceuticals Shares Slip 6.9% After FDA Says Drug Application Not ReadySupernus Pharmaceuticals Shares Slip 6.9% After FDA Says Drug Application Not Ready
marketwatch.com - April 8 at 5:26 PM
Stocks to Watch: Intel, Vanda Pharmaceuticals, OneMedNetStocks to Watch: Intel, Vanda Pharmaceuticals, OneMedNet
marketwatch.com - April 4 at 10:40 AM
How Much Does It Cost To Make Novo Nordisks Ozempic? Shockingly Low Against $1,000 Price Tag, Study ShowsHow Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows
msn.com - March 28 at 3:36 PM
ELDN Eledon Pharmaceuticals, Inc.ELDN Eledon Pharmaceuticals, Inc.
seekingalpha.com - March 28 at 10:35 AM
Sanders calls for Novo Nordisk to slash Ozempic, Wegovy pricesSanders calls for Novo Nordisk to slash Ozempic, Wegovy prices
msn.com - March 27 at 7:22 PM
Buy Rating Affirmed for Esperion on Growth Potential Post-FDA ApprovalBuy Rating Affirmed for Esperion on Growth Potential Post-FDA Approval
markets.businessinsider.com - March 25 at 4:29 PM
Novo Nordisk Agrees to Buy Cardior for Up to €1 Billion (1)Novo Nordisk Agrees to Buy Cardior for Up to €1 Billion (1)
news.bloomberglaw.com - March 25 at 9:21 AM
Novo Nordisk targets heart disease in $1.1 billion dealNovo Nordisk targets heart disease in $1.1 billion deal
msn.com - March 25 at 9:21 AM
INO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023INO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023
markets.businessinsider.com - March 6 at 10:34 PM
Ampio Pharmaceuticals Up 26% on Securities-Sale UpdatesAmpio Pharmaceuticals Up 26% on Securities-Sale Updates
marketwatch.com - February 28 at 6:13 PM
The Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 10 ExpertsThe Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 10 Experts
markets.businessinsider.com - February 27 at 10:35 AM
iBio stock jumps on sale of preclinical PD-1 agonist antibody programiBio stock jumps on sale of preclinical PD-1 agonist antibody program
msn.com - February 26 at 8:43 AM
Iovance rallies nearly 40% on FDA approval, stock offeringIovance rallies nearly 40% on FDA approval, stock offering
msn.com - February 20 at 2:10 PM
Wexford pharmaceutical company expands antiviral initiativesWexford pharmaceutical company expands antiviral initiatives
bizjournals.com - February 9 at 9:06 PM
Novo Nordisk Has a Weight-Loss Pill But Can’t Make It YetNovo Nordisk Has a Weight-Loss Pill But Can’t Make It Yet
msn.com - February 9 at 10:55 AM
Citius Pharmaceuticals Inc (CTXR)Citius Pharmaceuticals Inc (CTXR)
investing.com - February 8 at 2:18 AM
InnovAge Holding Corp. (NASDAQ:INNV) Q2 2024 Earnings Call TranscriptInnovAge Holding Corp. (NASDAQ:INNV) Q2 2024 Earnings Call Transcript
insidermonkey.com - February 7 at 11:08 AM
Apellis Pharmaceuticals Inc (APLS)Apellis Pharmaceuticals Inc (APLS)
investing.com - February 5 at 1:50 PM
Novo Nordisk Spends $11 Billion on Meeting Obesity Drug DemandNovo Nordisk Spends $11 Billion on Meeting Obesity Drug Demand
msn.com - February 5 at 8:50 AM
TRACON Pharmaceuticals Inc (TCON)TRACON Pharmaceuticals Inc (TCON)
uk.investing.com - February 2 at 9:20 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

American Bio Medica logo

American Bio Medica

OTCMKTS:ABMC
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to unaffiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, North America, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.
Auris Medical logo

Auris Medical

NASDAQ:EARS
Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
Global Future City logo

Global Future City

OTCMKTS:FTCY
Global Future City Holding, Inc. is an holding company. It focused in the areas of consumer product sales and EB-5 investments. The company was founded on October 12, 2000 and is headquartered in Irvine, CA.
Innovus Pharmaceuticals logo

Innovus Pharmaceuticals

OTCMKTS:INNVD
Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality. The company also offers Beyond Human testosterone booster, ketones, krill oil, omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; UriVarx, a supplement for overactive bladder and urinary incontinence; PEVarx, a supplement for peak sexual performance; ProstaGorx, a supplement for prostate support; and FlutiCare, a nasal spray. In addition, its products include Apeaz for pain relief; AllerVarx for allergy relief; ArthriVarx for joint pain; Xyralid, a hemorrhoid cream; Can-C eye drop and eye care capsule; MZS, a melatonin formula to enhance sleep patterns; and Diabasens, a diabetic foot cream. The company's pipeline products comprise UriVarx for urinary tract infection; Xyralid suppositories for hemorrhoidal symptoms; GlucoGorx supplement, glucometer, lancing device, and GlucoGorx strip for blood sugar levels; Vesele and RecalMax nitric oxide strips. It markets and sells its products through commercial partners to primary care physicians, urologists, gynecologists, and therapists, as well as to other healthcare providers; and directly to consumers through online channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.